Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.48 USD | +0.68% | +4.96% | +46.53% |
03-04 | Passage Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-04 | Passage Bio, Inc. Appoints Kathleen Borthwick as Chief Financial Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+46.53% | 91.19M | |
+5.66% | 111B | |
+11.23% | 105B | |
-2.15% | 21.93B | |
-12.15% | 22.34B | |
-5.94% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- PASG Stock
- News Passage Bio, Inc.
- Wedbush Adjusts Passage Bio Price Target to $6 From $9, Maintains Outperform Rating